InvestSMART

Anteris Technologies Ltd (ASX: AVR) - Announcements

- Current share price for AVR : $10.970

ASX company news and announcements for Anteris Technologies Ltd (AVR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Anteris Technologies Ltd (AVR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Anteris Technologies Ltd (AVR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Anteris Technologies Ltd (AVR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,062 Cleansing Notice 22 Dec 2023 10:24AM $19.100 $10.900 fallen by 42.93%
$1,062 Application for quotation of securities - AVR 21 Dec 2023 2:57PM $19.150 $10.900 fallen by 43.08%
$1,062 Update on Equity Raising 15 Dec 2023 7:07PM $19.570 $10.900 fallen by 44.30%
$1,062 Notification regarding unquoted securities - AVR 28 Nov 2023 4:48PM $19.600 $10.900 fallen by 44.39%
$1,062 Cleansing Notice 22 Nov 2023 9:26AM $20.200 $10.900 fallen by 46.04%
$1,062 Application for quotation of securities - AVR 21 Nov 2023 6:14PM $20.200 $10.900 fallen by 46.04%
$1,062 30-day Haemodynamic Results from the DurAVR US EFS Trial 21 Nov 2023 9:53AM $19.800 $10.900 fallen by 44.95%
$1,062 Change in substantial holding 7 Nov 2023 10:57AM $19.020 $10.900 fallen by 42.69%
$1,062 Change in substantial holding 3 Nov 2023 6:03PM $19.300 $10.900 fallen by 43.52%
$1,062 Cleansing Notice 3 Nov 2023 2:46PM $19.500 $10.900 fallen by 44.10%
$1,062 Application for quotation of securities - AVR 3 Nov 2023 9:57AM $20.000 $10.900 fallen by 45.50%
$1,062 Notification of cessation of securities - AVR 1 Nov 2023 12:55PM $19.750 $10.900 fallen by 44.81%
$1,062 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2023 9:50AM $20.110 $10.900 fallen by 45.80%
$1,062 Cleansing Notice 26 Oct 2023 12:46PM $20.600 $10.900 fallen by 47.09%
$1,062 Reinstatement to Official Quotation 26 Oct 2023 9:59AM $20.650 $10.900 fallen by 47.22%
$1,062 Proposed issue of securities - AVR 26 Oct 2023 9:59AM $20.650 $10.900 fallen by 47.22%
$1,062 Capital Raise 26 Oct 2023 9:59AM $20.650 $10.900 fallen by 47.22%
$1,062 Positive Results from Interim Analysis of DurAVR EFS Trial 25 Oct 2023 5:15PM $20.650 $10.900 fallen by 47.22%
$1,062 Suspension from Official Quotation 25 Oct 2023 9:41AM $20.650 $10.900 fallen by 47.22%
$1,062 Application for quotation of securities - AVR 24 Oct 2023 6:42PM $20.650 $10.900 fallen by 47.22%
$1,062 Trading Halt 23 Oct 2023 9:29AM $20.650 $10.900 fallen by 47.22%
$1,062 Anteris Completes DurAVR THV EFS Enrolment 17 Oct 2023 1:27PM $20.490 $10.900 fallen by 46.80%
$1,062 R&D Refund 13 Oct 2023 9:54AM $20.560 $10.900 fallen by 46.98%
$1,062 Notification of cessation of securities - AVR 6 Oct 2023 1:21PM $20.340 $10.900 fallen by 46.41%
$1,062 Cleansing Notice 29 Sep 2023 2:11PM $20.490 $10.900 fallen by 46.80%

301 - 325 of 714 results

Page 13 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.